String-shaped nanoparticles filled with antibiotics are seen coating an algae cell colored in green.

Chlamydomonas reinhardtii algae studded with humanized nanoparticles can dodge immune cells for up to three days while delivering antibiotics.

Credit: Fangyu Zhang and Zhengxing Li

Algae microrobots fight persistent bacterial infections

Bioengineers used a modular, step-by-step chemical technique to create algae that carry antibiotic payloads.
Dan Samorodnitsky
| 3 min read
Register for free to listen to this article
Listen with Speechify
0:00
3:00

Antibiotics are not particularly sophisticated medicines. They simply circulate in the bloodstream or dissolve in the stomach and must exert their influence quickly before being degraded or excreted. For persistent infections, this might not be good enough.

A new invention birthed from a collaboration between two bioengineers makes antibiotics more precise and persistent in the body. Rather than a passive dose of antibiotics, the bioengineers attached the drugs to “microrobots” made of algae. They described their invention in a recent publication in Nature Materials (1). 

“There was a lot of brainstorming and discussion to come up with the idea of algae robots,” said Liangfang Zhang, a bioengineer at the University of California, San Diego (UCSD) and coauthor of the study. 

Previously, scientists coated microscopic pieces of metal, like zinc or copper with antibiotics (2). This approach works for oral antibiotic delivery where nanoparticles pass through the digestive tract before excretion, but it won’t work in parts of the body that are harder to clear. “You cannot leave anything behind in the lungs or other organs,” said Zhang. The team needed a new way to deliver antibiotics.

Zhang’s group landed on algae cells for a few reasons. A microrobot delivery system would need to be big enough to carry a dose of medicine, but small enough to penetrate deep into tissues. Chlamydomonas reinhardtii, a species of algae that is about 10 micrometers long is a neat, medium size. 

A black and white microscope image of algae cells with tail-like flagella dragging behind them.
Chlamydomonas reinhardtii algae cells — when they’re not coated in nanoparticles — are a common laboratory model organism.
credit: wikipedia

Zhang teamed up with Joseph Wang, a fellow bioengineer in the same department at UCSD. Zhang’s and Wang’s teams filled biodegradable nanoparticles with antibiotics. Then they coated the nanoparticles with cell membranes derived from human immune cells, which made the nanoparticles look more human-like and avoided immune system activation. Finally, using click chemistry, a modular chemical method of attaching molecules to each another, they fused the coated nanoparticles to the outside of algae cells, like buttons on a shirt.

Zhang and Wang tested the microrobot’s ability to deliver the antibiotic-filled nanoparticles and clear infections in mice infected with Pseudomonas aeruginosa, a common cause of pneumonia that frequently develops resistance to antibiotics (3). The teams squirted the microrobots down a feeding tube into infected mouse lungs. The microrobots swam randomly through the lungs and actively delivered antibiotics to the body longer than antibiotics delivered conventionally. 

The random swimming was key. Traditional antibiotics passively float around and unevenly diffuse drugs across tissues. The algae zigged and zagged, dodging immune cells that slowly chased after them. This meant that the drug reached all corners of the lung. The persistent swimming paid off; the microrobots required a 3000-fold lower dose of antibiotics to clear the infection than an intravenous transfusion of the same antibiotics against the same bacteria.

The microrobots cleared the infections within one week, and all mice that received the treatment were still alive 30 days later. Infected mice that received no treatment died within three days. Once the algae cell microrobots delivered their antibiotic payloads, immune cells captured and digested the algae within 72 hours.

“This is a highly interesting project. In the past, bioinspired bots were usually based on synthetic micro/nanorobots or bacteria,” said Wei Gao a medical engineer at California Institute of Technology who wasn’t involved in the research. “Synthetic microrobots face limitations in realizing efficient propulsion in vivo, while bacteria-based bots raise safety concerns for in vivo applications.” 

Nevertheless, the immune system’s response to algae-based microrobots is still not fully understood. Gao suspects that scientists will need to improve the retention time in the body to make microrobots a viable drug delivery system. 

Just a week after publishing their work on clearing lung infections, Zhang and Wang demonstrated another drug delivery system powered by algae to shuttle chemotherapeutics inside a pill into the gastrointestinal tract (4). The next step for the researchers is to figure out how to make their algae drug delivery system work in humans.

“We can click nanoparticles onto algae. But we don’t know how reliable that process is when you [expand] out from this very small scale to larger scale,” said Zhang.

References

  1. Zhang, F. et al. Nanoparticle-modified microrobots for in vivo antibiotic delivery to treat acute bacterial pneumonia. Nat. Mater. (2022). doi:10.1038/s41563-022-01360-9
  2. Allahverdiyev, A. M., Kon, K. V., Abamor, E. S., Bagirova, M. & Rafailovich, M. Coping with antibiotic resistance: combining nanoparticles with antibiotics and other antimicrobial agents. Expert Review of Anti-infective Therapy  9, 1035–1052 (2011).
  3. Pang, Z., Raudonis, R., Glick, B. R., Lin, T.-J. & Cheng, Z. Antibiotic resistance in Pseudomonas aeruginosa: mechanisms and alternative therapeutic strategies. Biotechnology Advances  37, 177–192 (2019).
  4. Zhang, F. et al. Gastrointestinal tract drug delivery using algae motors embedded in a degradable capsule. Sci Robot  7, eabo4160 (2022).

About the Author

  • Dan Samorodnitsky
    Dan earned a PhD in biochemistry from SUNY Buffalo and completed postdoctoral fellowships at the USDA and Carnegie Mellon University. He is a freelance writer whose work has appeared in Massive Science, The Daily Beast, VICE, and GROW. Dan is most interested in writing about how molecules collaborate to create body-sized phenomena.

Related Topics

Loading Next Article...
Loading Next Article...
Subscribe to Newsletter

Subscribe to our eNewsletters

Stay connected with all of the latest from Drug Discovery News.

Subscribe

Sponsored

Gold circles with attached purple corkscrew shapes represent gold nanoparticles against a black background.

Driving gene therapy with nonviral vectors 

Learn why nonviral vectors are on the rise in gene therapy development.
A 3D digital illustration of a viral spike protein on a cell surface, surrounded by colorful, floating antibodies in the background

Milestone: Leapfrogging to quantitative, high throughput protein detection and analysis

Researchers continuously push the boundaries of what’s possible with protein analysis tools.
Blue cancer cells attached to a cellular surface against a bright blue background in a 3D rendering of a cancer infection.

Advancing immuno-oncology research with cellular assays

Explore critical insights into immunogenicity and immunotoxicity assays for cancer therapies.
Drug Discovery News November 2024 Issue
Latest IssueVolume 20 • Issue 6 • November 2024

November 2024

November 2024 Issue

Explore this issue